英国基层慢阻肺患者姑息治疗接受率低
这项基于英国电子健康记录的队列研究(2004-2015年)纳入92 365例慢阻肺患者,评估基层姑息治疗支持情况。仅7.8%全队列和21.4%死亡患者接受姑息治疗,肺癌是接受姑息治疗的主导因素而非慢阻肺本身。
要点
- 英国基层慢阻肺患者姑息治疗接受率仅7.8%,死亡患者中也仅21.4%。
- 肺癌共诊断是慢阻肺患者接受姑息治疗的最强关联因素。
- 无肺癌的死亡慢阻肺患者仅16.7%接受姑息治疗,有肺癌者达56.5%。
核心结论
- 英国基层慢阻肺患者的姑息治疗支持提供不足。
- 肺癌而非慢阻肺是慢阻肺患者接受姑息治疗的主导驱动因素。
研究设计与样本
- 全国代表性队列研究,使用2004-2015年电子健康记录。
- 纳入92 365例符合条件的慢阻肺患者,其中26 135例死亡。
- 采用逻辑回归分析全队列和死亡患者中与接受姑息治疗相关的因素。
主要发现
- 全队列中仅7.8%接受姑息治疗,死亡患者中仅21.4%接受姑息治疗。
- 全队列中肺癌与姑息治疗强关联(OR 14.1,95%CI 13.1-15)。
- 死亡患者中肺癌与姑息治疗强关联(OR 6.5,95%CI 6-7)。
- 无肺癌的死亡慢阻肺患者仅16.7%接受姑息治疗,有肺癌者达56.5%。
- 接受姑息治疗者中,肺癌共诊断增加生命最后一个月之前接受姑息治疗的机会(1-6个月 vs ≤1个月:风险比1.4,95%CI 1.3-1.7)。
临床怎么用
- 基层应主动识别慢阻肺患者姑息治疗需求,不应仅因合并肺癌才启动。
- 对重度慢阻肺患者应常规评估姑息治疗支持,减少疾病间不平等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mortality and symptom burden from chronic obstructive pulmonary disease (COPD) and lung cancer are similar but there is thought to be an inequality in palliative care support (PCS) between diseases. This nationally representative study assessed PCS for COPD patients within primary care in the UK.This was a cohort study using electronic healthcare records (2004-2015). Factors associated with receiving PCS were assessed using logistic regression for the whole cohort and deceased patients.There were 92 365 eligible COPD patients, of which 26 135 died. Only 7.8% of the whole cohort and 21.4% of deceased patients received PCS. Lung cancer had a strong association with PCS compared with other patient characteristics, including Global Initiative for Chronic Obstructive Lung Disease stage and Medical Research Council Dyspnoea score (whole cohort, lung cancer: OR 14.1, 95% CI 13.1-15; deceased patients, lung cancer: OR 6.5, 95% CI 6-7). Only 16.7% of deceased COPD patients without lung cancer received PCS compared with 56.5% of deceased patients with lung cancer. In patients that received PCS, lung cancer co-diagnosis significantly increased the chances of receiving PCS before the last month of life (1-6 versus ≤1 month pre-death: risk ratio 1.4, 95% CI 1.3-1.7).Provision of PCS for COPD patients in the UK is inadequate. Lung cancer, not COPD, was the dominant driver for COPD patients to receive PCS.
引用
- Bloom CI, Slaich B, Morales DR, et al. Low uptake of palliative care for COPD patients within primary care in the UK. Eur Respir J. 2018. PMID: 29444916. doi:10.1183/13993003.01879-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。